Lebo Sun

581 total citations
21 papers, 429 citations indexed

About

Lebo Sun is a scholar working on Molecular Biology, Cancer Research and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Lebo Sun has authored 21 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Cancer Research and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Lebo Sun's work include MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers) and RNA modifications and cancer (5 papers). Lebo Sun is often cited by papers focused on MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers) and RNA modifications and cancer (5 papers). Lebo Sun collaborates with scholars based in China. Lebo Sun's co-authors include Guofeng Shao, Dawei Zheng, Linwen Zhu, Li Ni, Guodong Xu, Qingyun Zhou, Ni Li, Ni Li, Qiaoling Pan and Limin Xu and has published in prestigious journals such as PLoS ONE, Scientific Reports and BioMed Research International.

In The Last Decade

Lebo Sun

20 papers receiving 420 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lebo Sun China 11 325 175 42 35 30 21 429
Dawei Zheng China 13 462 1.4× 225 1.3× 61 1.5× 99 2.8× 50 1.7× 30 620
Claudia Mandolini Italy 9 335 1.0× 328 1.9× 49 1.2× 25 0.7× 68 2.3× 15 521
Yukiko Nakayama Japan 6 165 0.5× 79 0.5× 35 0.8× 33 0.9× 22 0.7× 9 451
Daria Domańska-Senderowska Poland 11 151 0.5× 117 0.7× 42 1.0× 55 1.6× 35 1.2× 25 362
Tarryn Willmer South Africa 10 200 0.6× 50 0.3× 18 0.4× 56 1.6× 30 1.0× 18 300
Paul Kay United Kingdom 8 190 0.6× 54 0.3× 30 0.7× 39 1.1× 50 1.7× 11 376
Xingyu Zhou China 13 411 1.3× 279 1.6× 21 0.5× 113 3.2× 38 1.3× 29 552
Tadahiro Oonishi Japan 12 149 0.5× 84 0.5× 21 0.5× 93 2.7× 40 1.3× 16 374
Sebastian Vencken Ireland 12 212 0.7× 152 0.9× 17 0.4× 79 2.3× 44 1.5× 25 365
Xue Cao China 8 170 0.5× 113 0.6× 12 0.3× 28 0.8× 11 0.4× 11 329

Countries citing papers authored by Lebo Sun

Since Specialization
Citations

This map shows the geographic impact of Lebo Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lebo Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lebo Sun more than expected).

Fields of papers citing papers by Lebo Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lebo Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lebo Sun. The network helps show where Lebo Sun may publish in the future.

Co-authorship network of co-authors of Lebo Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Lebo Sun. A scholar is included among the top collaborators of Lebo Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lebo Sun. Lebo Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Ni, et al.. (2025). Potential Diagnostic Value of Circular RNA hsa_circ_0008882 in Rheumatic Valvular Heart Disease. International Journal of General Medicine. Volume 18. 6961–6973.
2.
Zhu, Linwen, et al.. (2024). Genetic causal association between lipidomic profiles, inflammatory proteomics, and aortic stenosis: a Mendelian randomization investigation. European journal of medical research. 29(1). 446–446. 2 indexed citations
3.
Li, Ni, Tianyuan Zhang, Linwen Zhu, et al.. (2023). Recent Advances of Using Exosomes as Diagnostic Markers and Targeting Carriers for Cardiovascular Disease. Molecular Pharmaceutics. 20(9). 4354–4372. 5 indexed citations
4.
Xu, Guodong, Hang Chen, Jiabin Chen, et al.. (2022). Eukaryotic initiation factor 5A2 mediates hypoxia-induced autophagy and cisplatin resistance. Cell Death and Disease. 13(8). 683–683. 21 indexed citations
5.
Zhu, Linwen, et al.. (2022). The diagnostic value of has_circ_0006423 in non-small cell lung cancer and its role as a tumor suppressor gene that sponges miR-492. Scientific Reports. 12(1). 13722–13722. 5 indexed citations
6.
Ni, Li, Linwen Zhu, Lebo Sun, & Guofeng Shao. (2021). The effects of novel coronavirus (SARS-CoV-2) infection on cardiovascular diseases and cardiopulmonary injuries. Stem Cell Research. 51. 102168–102168. 19 indexed citations
7.
Li, Ni, Linwen Zhu, Hua Zhou, et al.. (2021). BMPR2 promoter methylation and its expression in valvular heart disease complicated with pulmonary artery hypertension. Aging. 13(22). 24580–24604. 7 indexed citations
8.
Zhu, Linwen, Li Ni, Lebo Sun, Dawei Zheng, & Guofeng Shao. (2020). Non-coding RNAs: The key detectors and regulators in cardiovascular disease. Genomics. 113(1). 1233–1246. 68 indexed citations
9.
Li, Ni, Linwen Zhu, Hua Zhou, et al.. (2020). miRNA-1183-targeted regulation of Bcl-2 contributes to the pathogenesis of rheumatic heart disease. Bioscience Reports. 40(11). 7 indexed citations
10.
Ni, Li, Hua Zhou, Dawei Zheng, et al.. (2020). Efficient detection of differentially methylated regions in the genome of patients with thoracic aortic dissection and association with MMP2 hypermethylation. Experimental and Therapeutic Medicine. 20(2). 1073–1081. 8 indexed citations
11.
Pan, Qiaoling, Lebo Sun, Dawei Zheng, et al.. (2018). MicroRNA-9 Enhanced Cisplatin Sensitivity in Nonsmall Cell Lung Cancer Cells by Regulating Eukaryotic Translation Initiation Factor 5A2. BioMed Research International. 2018. 1–8. 20 indexed citations
12.
Zheng, Dawei, Xiaoying Chen, Ni Li, et al.. (2017). Differentially methylated regions in patients with rheumatic heart disease and secondary pulmonary arterial hypertension. Experimental and Therapeutic Medicine. 14(2). 1367–1372. 10 indexed citations
13.
Xu, Guodong, Guofeng Shao, Qiaoling Pan, et al.. (2017). MicroRNA-9 regulates non-small cell lung cancer cell invasion and migration by targeting eukaryotic translation initiation factor 5A2.. PubMed. 9(2). 478–488. 36 indexed citations
14.
Li, Ni, Dawei Zheng, Lebo Sun, et al.. (2016). Hypermethylation of brain natriuretic peptide gene is associated with the risk of rheumatic heart disease. Bioscience Reports. 37(1). 3 indexed citations
15.
Li, Ni, Jiangfang Lian, Sheng Zhao, et al.. (2015). Detection of Differentially Expressed MicroRNAs in Rheumatic Heart Disease: miR-1183 and miR-1299 as Potential Diagnostic Biomarkers. BioMed Research International. 2015. 1–11. 34 indexed citations
16.
17.
Zheng, Dawei, Limin Xu, Lebo Sun, et al.. (2014). Comparison of the Ventricle Muscle Proteome between Patients with Rheumatic Heart Disease and Controls with Mitral Valve Prolapse: HSP 60 May Be a Specific Protein in RHD. BioMed Research International. 2014. 1–9. 8 indexed citations
18.
Xu, Limin, Dawei Zheng, Lingyan Wang, et al.. (2014). GCKGene-Body Hypomethylation Is Associated with the Risk of Coronary Heart Disease. BioMed Research International. 2014. 1–7. 31 indexed citations
19.
Jiang, Danjie, Dawei Zheng, Lingyan Wang, et al.. (2013). Elevated PLA2G7 Gene Promoter Methylation as a Gender-Specific Marker of Aging Increases the Risk of Coronary Heart Disease in Females. PLoS ONE. 8(3). e59752–e59752. 72 indexed citations
20.
Xu, Guodong, et al.. (2013). Down-regulation of eIF5A-2 prevents epithelial-mesenchymal transition in non-small-cell lung cancer cells. Journal of Zhejiang University SCIENCE B. 14(6). 460–467. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dawei Zheng Breakdown of academic impact, for papers by Claudia Mandolini Breakdown of academic impact, for papers by Yukiko Nakayama Breakdown of academic impact, for papers by Daria Domańska-Senderowska Breakdown of academic impact, for papers by Tarryn Willmer Breakdown of academic impact, for papers by Paul Kay Breakdown of academic impact, for papers by Xingyu Zhou Breakdown of academic impact, for papers by Tadahiro Oonishi Breakdown of academic impact, for papers by Sebastian Vencken Breakdown of academic impact, for papers by Xue Cao
Rankless by CCL
2026